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1. Introduction
The gut hosts a complex and diverse population of 
commensal bacteria collectively known as the gut microbiota, 
which has increasingly been implicated in host metabolism, 
immunity, nervous system function and disease (Backhed 
et al., 2005; Cryan and Dinan, 2012; Diaz Heijtz et al., 2011; 
Grenham et al., 2011). Colonisation of the human gut is post-
natal and commences upon exposure to bacteria during birth. 
During the first year of life the microbiota has a maternal 
signature, however, it evolves fairly quickly and reaches adult-
like complexity after 1-3 years (Grenham et al., 2011; Mackie 
et al., 1999; Palmer et al., 2007). Numerous factors have been 
shown to influence gut microbiota composition, including 
diet, disease, and host age and genetics (Claesson et al., 2011; 
Gulati et al., 2012; Wu and Hui, 2011). The composition 
of the microbiota seems to maintain a personal ‘signature’ 
which may be transiently altered by antibiotics, infection 
and diseases (Forsythe et al., 2010; Manichanh et al., 2010). 
Thus, despite a significant interpersonal and inter-special 
variation, the enteric microbiota seems to be characterised 
by a balance and composition that is unique and beneficial 
to the individual host, and disruption of this balance causes 
disease susceptibility (Diaz Heijtz et al., 2011). To this extent, 
it is important to characterise the biological mechanisms 
through which the host can maintain the composition of 
the gut microbiota and how this relationship is affected 
during pathological states.
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Abstract
The enteric microbiota is characterised by a balance and composition that is unique to the host. It is important to 
understand the mechanisms through which the host can maintain the composition of the gut microbiota. MicroRNAs 
(miRNA) are implicated in intercellular communication and have been isolated from bodily fluids including stool. 
Recent findings suggest that miRNA produced by the host’s intestinal epithelial cells (IECs) participate in shaping 
the microbiota. To investigate whether miRNA expression was influenced by the gut microbiota we measured the 
expression of miRNAs expressed by intestinal epithelial cells in faeces. Specifically, we measured miRNA expression 
in faeces from germ-free (GF) and conventional mice and similarly in a rat model of antibiotic-mediated depletion 
of the gut microbiota control rats. In adult male GF and conventional mice and adult Sprague Dawley (SD) rats were 
treated with a combination of antibiotics for 8 weeks; total RNA was extracted from faecal pellets taken at week 0, 
2, 4, 6 week 8 and the expression of let-7b-3p, miR-141-3p, miR-200a-3p and miR-1224-5p (miRNAs known to be 
expressed in IECs) were measured relative to U6 at each time point using qRT-PCR. In GF animals the expression 
of let-7b, miR-141 and miR-200a in faeces was lower compared to conventional mice. Following antibiotic-mediated 
depletion of gut microbiota, rats showed two divergent profiles of miRNA expression. Following two weeks of 
antibiotic treatment, the expression of let-7b and miR-1224 dropped significantly and remained low for the remainder 
of the study. The expression of miR-200a and miR-141 was significantly higher at week 2 than before antibiotic 
treatment commenced. Subsequently, the expression of miR-200a and miR-141 decreased at week 4 and continued 
to decrease at week 6. This data demonstrates that miRNAs can be used as an independent, non-invasive marker 
of microbial fluctuations along with gut pathology in the intestine.
Keywords: microbiota, microRNA, enteric, stool, host
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MicroRNAs (miRNAs) are small, non-coding RNAs 
synthesised in the nucleus and functional in the cytoplasm, 
where they are involved in regulating transcription (Bartel, 
2004). Bacteria express non-coding RNAs, but they differ 
from miRNA in size (50-500 nucleotides in length) and 
structure, including the number of stem-loops (Viegas 
and Arraiano, 2008). The oral pathogen Streptococcus 
sanguinis was recently shown to release a number of 
small RNAs in micro vesicles suggested to be involved 
in bacteria-to bacteria communication and in addition 
bacteria-to-host communication (Choi et al., in press). 
Recently, host miRNAs have been implicated in intercellular 
communication and have been isolated from body fluids 
including stool (Ahmed et al., 2012, Mittelbrunn and 
Sánchez-Madrid, 2012, Weber et al., 2010). The functional 
role of miRNAs in host-microbe communication is only 
beginning to be understood. It has recently been shown 
that the microbiota regulates gene expression in the 
colon of mice (Dalmasso et al., 2011) and recent findings 
seem to suggest that miRNAs produced by the host’s 
intestinal epithelial cells IECs participate in shaping the 
gut microbiota and affect bacterial growth (Liu et al., 2016). 
Detection of miRNA isolated from the faeces of rodents 
may offer the potential to monitor this relationship in live 
animals in a temporal fashion. To further investigate this 
possibility, we aimed to determine the effect of bacterial 
status on the expression of key microRNAs expressed by 
IEC’s in GF mice and in a rat model of antibiotic-mediated 
depletion of the gut microbiota.
2. Materials and methods
Germ-free mice
All experiments were conducted in accordance with 
European Directive 86/609/EEC. Approval by the Animal 
Experimentation Ethics Committee of University College 
Cork was obtained before commencement of all animal 
related experiments. Adult male germ-free (GF) and 
conventional (CON) C57/Bl6 breeding pairs were obtained 
from Taconic (Germantown, NY, USA) and first generation 
mice were used. GF mice were housed in gnotobiotic 
isolators under a strict 12-h light/dark cycle in cages of 4-5 
animals. CON mice are similarly housed under regulated 
conditions (temperature 20-21 °C, 55-60% humidity), under 
the same 12 h light/dark cycle and housed 4-5 per cage. 
Autoclaved, pelleted diets were the same for both groups 
(Special Diet Service, Essex, UK, product code 801010). 
Faecal pellets were obtained at 8 weeks old. Fresh faecal 
pellets were collected and stored at -80 °C.
Animals, antibiotic treatment
Adult male Sprague Dawley rats (n=10/group) (Envigo, 
Alconbury, UK) were housed 5 per cage in standard rat 
cages. All animals were housed in a standard animal facility 
under a strict 12-h light/dark cycle. All experimental groups 
received the same autoclaved diet (Teklad Global 18% 
Protein Rodent diet, Product code 2018S). Approval by the 
Animal Experimentation Ethics Committee of University 
College Cork was obtained before commencement of all 
animal related experiments. In order to sufficiently deplete 
the gut microbiota rats were treated with a combination of 
antibiotics for 8 weeks at adulthood (10 weeks old at start 
of treatment). The antibiotic cocktail was administered 
in drinking water to avoid possible adverse effects from 
chronic stress induced by alternative administration 
methods such as oral gavage. The antibiotic cocktail 
consisted of ampicillin (1 g/l), vancomycin (500 mg/l), 
and ciprofloxacin HCL (20 mg/l), imipenem (250 mg/l) 
and metronidazole (1 g/l). The antibiotic cocktail was 
chosen based on published protocols and was made up in 
autoclaved water and changed every 3 days (Hoban et al., 
2016). Animal weights were taken every 3 days to ensure 
animals were not losing excessive body weight. Along with 
regular weight monitoring, weekly fresh faecal pellets were 
collected to ensure microbiota depletion. Control animals 
received autoclaved water without any antibiotics which 
was also changed every 3 days. Fresh faecal pellets were 
collected once a week for 8 weeks and stored at -80 °C.
Total RNA extraction and quantitative real-time PCR
100 mg of faecal pellets from each animal were homogenised 
in miRVana™ lysis buffer using a bead beater. Total RNA 
(including miRNAs) was extracted using the miRVana™ 
Total RNA Isolation kit (Ambion; Thermo Fisher, Waltham, 
MA, USA) as per the manufacturer’s instructions. Purity 
and quantity were assessed using the Agilent bioanalyzer 
and a Nano-drop spectrophotometer (Agilent, Santa Clara, 
CA, USA). mRNA was reverse transcribed to cDNA using 
the miRCURY LNA™ cDNA synthesis kit II and cDNA 
was amplified using probe specific primers (Table 1) and 
Exilent SYBR green (all Exiqon, Vedbaek, Denmark). Assay 
and spike-in controls were used for normalisation and all 
assays were run in triplicate and expressed relative to U6 
at each time point. Melt-curve analysis was performed to 
ensure that only one source of amplification was present. 
Using the Grubbs test any outliers were removed and all 
data were analysed using the 2-ΔΔCt relative quantitation 
method (Livak and Schmittgen, 2001) and expressed as 
fold change compared to control values.
In-silico analysis of faecal miRNA target gene function
Pathway analysis was carried out with DIANA-miRPath 
v3.021 (Vlachos et al., 2015), using predicted microRNA 
targets from the DIANA-microT-CDS v5.0 algorithm49 
and Gene Ontology genesets derived from KEGG. The 
P-value threshold was set to 0.05 and MicroT threshold to 
0.8, statistical correction for multiple comparisons was used.
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Statistics
Data is presented as mean ± standard error of the mean 
(SEM). Unless otherwise stated, data were analysed using 
one-way ANOVA and subsequently the unpaired Student’s 
t-test. The level of statistical significance was set at P≤0.05. 
Statistical significance was indicated as follows: * indicates 
P<0.05, ** indicates P<0.01 and *** indicates P<0.001. Diana-
miRPath in-silico analysis statistics used Fisher’s exact test 
and false discovery rate estimation.
3. Results
Epithelial miRNAs in the faeces of germ-free mice are 
significantly reduced
MicroRNAs are stably expressed and secreted in the 
faeces of mice (Liu et al., 2016b). In an effort to identify if 
miRNA present in the faecal pellets of mice are affected 
by absence or depletion of the microbiota we performed 
a literature search and chose to measure the expression 
of four miRNAs previously shown to be expressed in the 
epithelial cells of mice (Lee et al., 2015). We initially chose 
4 miRNAs that were previously shown to be expressed in 
the intestinal epithelium (Lee et al., 2015). Expression of 
let-7b-3p, miR-141-3p, miR-200a-3p and miR-1224-5p 
were measured in faeces at 8 weeks of age and were chosen 
based on the literature and were measured relative to U6 
snRNA in conventional and germ-free mice. Mice born in 
a germ-free environment showed a significant reduction 
in expression of let-7b-3p, miR-141-3p and miR-200a-3p 
(Figure 1, P<0.05) compared with conventionally raised 
mice. The expression of miR-1224-5p was also lower in 
germ-free animals, however, this failed to reach statistical 
significance.
Antibiotic mediated depletion of the gut microbiota 
influences faecal miRNA expression in diverse patterns
Recognising that miRNA expression in the faeces of mice 
was influenced by the microbiota, we investigated if absence 
of bacteria from birth was required to see such reductions in 
miRNA expression. To this end we depleted the microbiota 
in rats using a cocktail of antibiotics previously described 
(Desbonnet et al., 2015). No weight loss was observed 
in control or antibiotic treated rats. We were able to 
detect miRNAs in the faecal pellets of rats, as others had 
previously shown was possible (John-Baptiste et al., 2012). 
We subsequently measured the expression of the same 
miRNAs (let-7b-3p, miR-141-3p, miR-200a-3p and miR-
1224-5p) in the faeces of rats at 8 weeks while undergoing 
antibiotic-mediated depletion of the gut microbiota over a 
13 week period. Interestingly, miRNA expression displayed 
a divergent pattern in response to the antibiotic treatment. 
Following two weeks of antibiotic treatment, the expression 
of let-7b-3p and miR-1224-5p was significantly lower 
(Figure 2A-B, P<0.001) and remained at the same level 
during antibiotic treatment for four, six and eight weeks of 
antibiotic treatment. In contrast to this expression pattern; 
following two weeks of antibiotic treatment, the expression 
of both miR-200a-3p and miR-141-3p was significantly 
higher than before the treatment (Figure 2C-D, P<0.05). 
At week 4 though, the expression of both miRNAs had 
returned to baseline and maintained this level until the 
end of the experiment.
Functionality of faecal miRNA target genes
MiRNAs negatively regulate target mRNA expression via 
repression or degradation (Bartel, 2004) and to verify the 
functionality of the miRNAs measured in this study we 
performed in silico analysis on the target genes of these 
miRNAs. Using DIANA-miRPath (Vlachos et al., 2015) we 
functionally annotated the target genes relevant to let-7b-
3p, miR-141-3p, miR-200a-3p and miR-1224-5p. DIANA-
miRPath assigns experimentally supported target genes of 
miRNAs (from DIANA-microT-CDS (Paraskevopoulou et 
al., 2013)) to KEGG pathways which allows a functionality 
of the miRNA to be inferred. This bioinformatic approach 
revealed a number pathways of functional relevance in our 
study. Specifically, a number of pathways relevant to the 
intestinal environment were significantly over-represented 
(Table 2). These included bacterial invasion of epithelial 
cells (let-7b-3p), pathways involved in mucin production 
(mmu-1224-5p) and both inflammable bowel disease (IBD) 
and immunoglobulin A (IgA) synthesis (miR-200a-3p). 
Furthermore, they provide a rational contact for future 
work in this area.
Table 1. miRNA probe details and sequence information.
Probe Product code Sequence Sequence reference
U6 snRNA 203907 CACGAATTTGCGTGTCATCCTT NR_004394.1 (primer detects mouse and rat transcripts)
let-7b-3p 205653 CUAUACAACCUACUGCCUUCCC MIMAT0004482
miR-141-3p 204504 UAACACUGUCUGGUAAAGAUGG MIMAT0000432
miR-200a-3p 204707 UAACACUGUCUGGUAACGAUGU MIMAT0000682
miR-1224-5p 2115039 GUGAGGACUGGGGAGGUGGAG MIMAT0005460
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Using metagenomic data recently published from our 
group (Hoban et al., 2016) we were able to correlate 
faecal miRNA expression in antibiotic-treated rats with 
relative abundance data from the faeces of the same rats 
at week 4 of the experiment (4 weeks after the start of 
antibiotic treatment) (Table 3). No correlation between 
the relative abundance of bacterial families was observed 
(data not shown), interestingly though, there was significant 
correlation between relative abundance of the phyla 
Bacteroidetes, and Firmicutes with miR-141-3p. Similarly, 
the phyla Actinobacteria, Bacteroidetes, Cyanobacteria, 
Firmicutes and Proteobacteria were significantly correlated 
with miR-200a-3p (Table 3). Interestingly, correlations were 
only observed in those miRNAs that increased significantly 
following the commencement of antibiotic administration.
4. Discussion
Recent studies have shown that host miRNAs exist 
extracellularly and may be indicative of specific disease 
states (Weber et al., 2010). Additionally, recent work has 
identified host faecal miRNAs as a normal component of 
both human and mouse faeces (Liu et al., 2016). It has only 
recently become clear that miRNAs may be altered in the 
presence of a disturbed gut microbiota (Dalmasso et al., 
2011). To this end we sought to identify if the expression 
of host miRNAs in the faeces were altered in germ-free 
mice and in rats whose microbiota has been depleted 
by antibiotics using qRT-PCR. We chose to analyse the 
expression of 4 key miRNAs; miR-1224-5p, miR-141-3p, 
miR-200a-3p and let-7b-3p. We selected these miRNAs 
on the basis that they are highly expressed and abundant 
in mouse faecal samples (Lee et al., 2015). In addition, 
the miRNA selected were also among the most abundant 
miRNAs isolated from human faecal samples and thus of 
further translational interest (Liu et al., 2016). Furthermore, 
these miRNAs are constitutively expressed in murine IECs, 
the most likely source of faecal miRNAs (Lee et al., 2015).
The interaction between the host and its resident 
microbiota is an intriguing one, and miRNAs are known 
to operate at this interface (Runtsch et al., 2014). Defining 
the molecular pathways involved in host-microbe crosstalk 
are essential for translational research and the search for 
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Figure 1. Host miRNA expression is altered in the faeces of germ-free mice. Total RNA is extracted from faecal pellets from germ-
free and conventional mice and gene expression for (A) let-7b-3p, (B) miR-200a-3p, (C) miR-1224-5p and (D) miR-141-3p were 
measured by qRT-PCR relative to U6 gene expression (n=5-6 per group). The expression of miR-200a, miR-141 and let-7b was 
significantly lower in germ-free animals (t9=2.571, P=0.0301; t9=2.351, P=0.0432; t7=2.685, P=0.0313). The expression of miR-1224 
in germ-free animals was also lower, without reaching statistical significance (t9=2.003, P=0.0853). Data is presented as mean ± 
standard error of the mean (SEM). * indicates P<0.05.
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alternative therapies for conditions in which changes in 
the microbiota are implicated. Dalmasso et al. (2011), 
recently demonstrated that in the colon of germ-free 
mice, a number of miRNAs are differentially expressed 
and that these miRNAs interact with epithelial cell ion 
transporters in a mechanism which may regulate host 
gene expression (Zhang et al., 2016). It is intriguing to the 
think that miRNAs in the faeces may represent a method 
of analysing host-microbe interactions in a live animal. 
In germ-free animals we observed significant reductions 
in miR-141-3p, miR-200a-3p and let-7b-3p, respectively. 
This data is in partial agreement with data reported by 
Dalmasso et al. (2011) in which the expression of a number 
of miRNAs different to those measured here were reduced 
in the germ-free colon. However, this data is at odds with 
recent sequencing data which found increased abundance of 
miRNA transcripts in GF mice. Using RNA sequencing Liu 
et al. (2016) found increases in global miRNA expression, 
including the miRNAs measured here albeit using a 
different technique. Reasons for this may be due to technical 
differences, this paper measured all detectable miRNAs in 
one sample whereby we have compared singular miRNA 
expression using a sensitive and quantitative method (Liu 
et al., 2016).
Germ-free rodents are different from antibiotic treated 
rodents in many physiological aspects as we and others 
have shown in regards behaviour (Hoban et al., 2016), 
the immune system and metabolism (Sudo et al., 2004). 
In addition, antibiotic treatment will eliminate different 
bacteria at different times. This suggests that miRNAs and 
bacteria may interact indirectly, such that genes targeted 
by specific miRNAs may be translationally repressed 
which subsequently influences epithelial cell structure 
and function which effects the microbiota (Goodrich et 
al., 2014). Moreover, eliminating the microbiota with 
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Figure 2. Depletion of the gut microbiota with antibiotics has divergent effects on host-miRNA secretion in faeces. Total RNA is 
extracted from faecal pellets from mice treated with an antibiotic cocktail and untreated mice and gene expression for (A) let-
7b-3p, (B) miR-200a-3p, (C) miR-1224-5p and (D) miR-141-3p were measured by qRT-PCR relative to U6 gene expression over an 
8 week treatment period at 2 week intervals (n=7-10 per group). Data is presented as mean ± standard error of the mean (SEM). 
* indicates P<0.05, **** indicates P<0.001.
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antibiotics at different developmental stages will have 
very distinct effects in the molecular architecture of the 
intestinal epithelium.
The detection of miRNAs in the faeces of rodents may offer 
a new method for measuring signalling events between the 
microbiota and the host epithelium on a temporal basis in 
live animals. To examine this, we measured the expression 
of miR-1224-5p, miR-141-3p, miR-200a-3p and let-7b-3p 
Table 2. Functional characterisation of faecal microRNAs.
KEGG pathway P-value
let-7b-3p
1 Pantothenate and CoA biosynthesis (mmu00770) 0.00389
2 Cell adhesion molecules (CAMs) (mmu04514) 0.00389
3 Bacterial invasion of epithelial cells (mmu05100) 0.00689
4 Glycerolipid metabolism (mmu00561) 0.02292
5 Biosynthesis of unsaturated fatty acids (mmu01040) 0.02380
miR-141-3p
1 Nicotine addiction (mmu05033) 0.00005
2 Gap junction (mmu04540) 0.00035
3 Thyroid hormone signalling pathway (mmu04919) 0.02383
4 Axon guidance (mmu04360) 0.04064
miR-200a-3p
1 Glycosaminoglycan biosynthesis-heparan sulphate/heparin (mmu00534) 0.0000001
2 Intestinal immune network for IgA production (mmu04672) 0.0140674
3 Inflammatory bowel disease (mmu05321) 0.0184161
mmu-1224-5p
1 Mucin type O-glycan biosynthesis (mmu00512) 0.003
2 Vitamin B6 metabolism (mmu00750) 0.041
3 Oestrogen signalling pathway (mmu04915) 0.049
Table 3. Correlation of faecal miRNA expression with phyla relative abundance.1
Phyla Acidobacteria Actinobacteria Bacteroidetes Cyanobacteria Firmicutes Proteobacteria
miR-141-3p
Pearson r 0.50 0.70 0.80 0.73 0.86 0.62
P-value 0.26 0.08 0.03 0.06 0.01 0.13
R2 0.25 0.49 0.64 0.53 0.74 0.39
let-7b-3p
Pearson r -0.58 -0.19 -0.22 0.40 -0.01 0.20
P-value 0.17 0.69 0.63 0.37 0.99 0.67
R2 0.34 0.03 0.05 0.16 0.00 0.04
miR-200a-3p
Pearson r 0.35 0.79 0.78 0.77 0.76 0.88
P-value 0.44 0.04 0.04 0.04 0.05 0.01
R2 0.12 0.62 0.60 0.60 0.58 0.78
miR-1224-5p
Pearson r -0.27 0.15 0.07 0.62 0.21 0.55
P-value 0.52 0.72 0.87 0.10 0.62 0.16
R2 0.07 0.02 0.00 0.39 0.04 0.30
1 Significant correlations are marked in bold Italic.
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in the faeces of rats before antibiotic treatment and every 2 
weeks thereafter up to 8 weeks. Previous work by Liu et al. 
(2016) has shown in mice using RNA sequencing that almost 
all luminal miRNAs are increased significantly following 
1 week of antibiotic treatment compared with specific 
pathogen free mice, albeit with a different antibiotic cocktail 
(ampicillin 1 mg/ml, vancomycin 500 mg/ml, neomycin 1 
mg/ml, metronidazole 1 mg/ml, and streptomycin 1 mg/
ml). Similarly, in rats, we found that the expression of 2 
of the miRNAs examined, miR-141-3p and miR-200a-
3p were significantly increased in faeces after 2 weeks. 
Subsequently though the expression of these miRNAs 
decreased to baseline levels at 6 weeks and remained at 
this level for the rest of the study. MiR-1224-5p and let-
7b-3p on the other hand displayed a rapid reduction in 
expression following 2 weeks of antibiotic treatment, a 
reduction that persisted up to 8 weeks. Our analysis of 
miRNA expression was conducted over an 8 week period, 
whereas Liu et al. (2016) measured miRNA expression at 
just 1 week. MiRNAs are expressed on numerous epithelial 
cell lineages in the intestine and these cells may be shed at 
different rates following antibiotic treatment and this may 
be reflected in the divergent pattern of miRNA secretion 
in faeces. MiRNA may exist in the lumen in 2 ways, firstly, 
exosomes released from almost all cell types and secondly 
‘naked’. All exosomes bare the molecular hallmarks of the 
cell from which they are derived. For example, miRNA 
derived from exosomes of epithelial origin will contain 
proteins, genes and miRNAs specifically associated with 
the epithelial cell (Schorey et al., 2015).
Let-7b-3p belongs to the let7 family of miRNAs which 
all show a generic response during bacterial infection of 
macrophage and epithelial cells to reduce the expression 
(post-transcriptionally) of IL-10 production (Schulte et al., 
2011). Mmu-let-7b-3p has also been shown to mediate the 
epithelial innate immune response via TLR signalling (Hu et 
al., 2009). Furthermore, let-7b is also known to target Tlr4 
and regulates the activation of NF-κB and the expression 
of downstream genes related to immune responses in 
Helicobacter pylori infection (Teng et al., 2013) while also 
binding to the Muc1 gene in epithelial cells (Inyawilert 
et al., 2015). miR-141-3p is expressed in immune cells 
(natural killer cells, leukocytes) and both inflamed and non-
inflamed epithelial cells in the small and large intestine (Lee 
et al., 2015). Similar to let-7b-3p, miR-141-3p is thought to 
target chemokines, increasing the production of Cxcl16 and 
Cxcl9 which drive inflammatory progression in IBD (Uza 
et al., 2011). miR-200a-3p belongs to the miR-18 family (of 
which miR-141-3p is a member also) and is expressed in 
epithelial cells throughout the body. Much of the biological 
function of this miRNA has been linked with cancer and 
in metastasis (Zang et al., 2016) and along with miR-141-
3p are enriched in the epithelial tissue. miR-1224-5p is 
expressed in the epithelial cells of both the small and large 
intestine where it is predicted to target the genes Aqp8 and 
Abcg2 in colitis (Lee et al., 2015). miR-1224-5p has been 
shown to be induced by lipopolysaccharides in vitro in a 
macrophage cell line (Niu et al., 2011) where it subsequently 
suppresses tumour necrosis factor alpha expression.
While faeces is considered a material waste it is also an 
extremely useful matrix for biological discovery. Firstly, it 
is consistently used as a source of biomarkers of diseases, 
such as IBD (calprotectin) and colon cancer (faecal occult 
blood). Secondly, it is non-invasive and is currently the 
source material for all faecal microbiota transplants in 
humans (and rodents) and finally, detection of mRNA in 
stool from infants has been used to monitor gastrointestinal 
development and maturation (Chapkin et al., 2010). We and 
other groups have shown that detection of miRNA in the 
faeces of rodents and humans is possible and quantitative 
(John-Baptiste et al., 2012; Liu et al., 2016; Weber et al., 
2010). Furthermore, specific cells in the intestinal crypt 
express a distinct repertoire of miRNAs that allow each 
cell type to be distinguished (Peck et al., 2017). The 
composition and expression levels of these miRNAs and 
how they relate to specific intestinal crypt cell types may 
indicate barrier function defects in pathological conditions. 
In fact, McKenna et al demonstrated using Dicer 1 (an 
enzyme essential for miRNA biogenesis) knock-out mice 
that miRNAs were essential for epithelial cell proliferation, 
differentiation, nutrient absorption, and that defective 
miRNA biogenesis was also responsible for impaired 
intestinal barrier function (McKenna et al., 2010). Further 
work is required to confirm this but we feel that given the 
central role miRNAs play in intestinal barrier function that 
this hypothesis is relevant. More evidence is required before 
measuring miRNAs in faeces provides adequate information 
in regards intestinal barrier function and integrity.
It has been shown that faecal miRNAs are present in 
extracellular vesicles, and that these vesicles are shed 
primarily from IECs and +4 niche-derived Hopx-expressing 
cells, such as Goblet and Paneth cells (Liu et al., 2016). In 
addition, recent work has demonstrated the use of faecal 
miRNAs as biomarkers of colorectal cancer (John-Baptiste 
et al., 2012), further investigation is warranted in this area 
but with the caveat that faecal miRNAs may be effected by 
antibiotic treatment as we have shown here. Further work 
is needed to determine the precise source of the miRNAs 
within the faeces, they may be exosomal or epithelial cell 
in origin and we have only identified alterations in four 
miRNAs. Both models used in this study are extreme 
models in regards microbial depletion, further work 
should look at less severe models of microbial perturbation, 
specifically, it would be interesting to profile miRNAs in a 
monoassociated germ-free model and also, is the pattern of 
miRNA expression changed based on whether the bacteria 
is commensal or pathogenic. Furthermore, further work 
should characterise the temporal pattern of all miRNAs, 
both abundant and rare transcripts. The work presented 
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here offers a potential method for screening the viability of 
the intestinal barrier in live animals and how it is effected in 
numerous pathological conditions. How the host interacts 
and tolerates the gut microbiota is a key tenet of research at 
the moment, we believe this method will contribute critical 
insights into this mutualism and demonstrate previously 
unknown cooperation between host and microbe.
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